Претраживање
Приказ резултата 1-3 од 3
Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer's disease in rats
(Taylor & Francis Ltd, Abingdon, 1997)
It is well known that disturbance of calcium homeostasis has a significant role in the development of neurodegenerative disorders, such as Alzheimer's disease (AD). Our recent data suggest that acute treatment with the ...
Open field behavior in nucleus basalis magnocellularis-lesioned rats treated with physostigmine and verapamil
(Taylor & Francis Ltd, Abingdon, 1997)
The present study was done to investigate and compare the effect of acetylcholinesterase inhibitor, physostigmine (0.030, 0.045, 0.060 and 0.075 mg/kg sc) and Ca-antagonist, verapamil (1.0, 2.5, 5.0 and 10.0 mg/kg sc) on ...
Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats
(Taylor & Francis Ltd, Abingdon, 1996)
Ten days after bilateral electrolytic lesions of nucleus basalis magnocellularis (NBM) we tested behavioral (spontaneous motor activity, acquisition and performance of two-way active avoidance, fear-response in open field ...